Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,351,475
-
Total 13F shares
-
50,199,378
-
Share change
-
+362,869
-
Total reported value
-
$151,099,311
-
Put/Call ratio
-
223%
-
Price per share
-
$3.01
-
Number of holders
-
61
-
Value change
-
+$1,340,397
-
Number of buys
-
28
-
Number of sells
-
27
Institutional Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q4 2023
As of 31 Dec 2023,
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,199,378 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, HARBOURVEST PARTNERS LLC, STATE OF WISCONSIN INVESTMENT BOARD, VANGUARD GROUP INC, BlackRock Inc., Artal Group S.A., Blue Owl Capital Holdings LP, PLATINUM INVESTMENT MANAGEMENT LTD, and CITIGROUP INC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.